Showing results (1701-1710 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|February 28, 2019
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled TrialFuxiao Li, Xiang Li, Chuanhai Guo, et al.
Pharmacoeconomics|August 28, 2019
A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USAElizabeth Wehler, Natalie Boytsov, Claudia Nicolay, et al.
Pharmacoeconomics|January 25, 2021
Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in SwedenRonan Mahon, Andrea Lang, Pamela Vo, et al.
Pharmacoeconomics|February 3, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United StatesAnita J Brogan, Sandra E Talbird, Ashley E Davis, et al.
Pharmacoeconomics|January 19, 2021
Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input DataMarina Treskova, Francisco Pozo-Martin, Stefan Scholz, et al.
Pharmacoeconomics|January 20, 2022
Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice ExperimentGabin F Morillon, Thomas G Poder
Pharmacoeconomics|February 28, 2014
Is individualized medicine more cost-effective? A systematic reviewMaximilian H M Hatz, Katharina Schremser, Wolf H Rogowski
Pharmacoeconomics|February 21, 2014
Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in BelgiumLieven Annemans, Mélanie Brignone, Sylvain Druais, et al.
Pharmacoeconomics|March 22, 2019
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Debra Fayter, Bram L T Ramaekers, et al.
Pharmacoeconomics|March 22, 2019
Parent Preferences for Health Outcomes Associated with Autism Spectrum DisordersTara A Lavelle, Milton C Weinstein, Joseph P Newhouse, et al.
Pageof 336